Wall Street Zen upgraded shares of Plexus (NASDAQ:PLXS – Free Report) from a buy rating to a strong-buy rating in a research report report published on Saturday morning.
PLXS has been the subject of a number of other research reports. Benchmark boosted their price target on Plexus from $160.00 to $165.00 and gave the company a “buy” rating in a research note on Monday, September 22nd. Stifel Nicolaus set a $140.00 price target on Plexus in a research note on Thursday, July 24th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Plexus in a research note on Wednesday. Williams Trading set a $165.00 price target on Plexus in a research note on Monday, September 22nd. Finally, Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and lifted their target price for the company from $135.00 to $150.00 in a research report on Friday, July 25th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $155.60.
Get Our Latest Research Report on Plexus
Plexus Stock Down 9.2%
Plexus (NASDAQ:PLXS – Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.19. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Plexus had a return on equity of 12.33% and a net margin of 4.04%.Plexus’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.45 earnings per share. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, equities analysts expect that Plexus will post 5.9 EPS for the current year.
Insider Transactions at Plexus
In other news, insider Victor (Pang Hau) Tan sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, August 28th. The stock was sold at an average price of $139.00, for a total value of $417,000.00. Following the completion of the transaction, the insider owned 8,723 shares of the company’s stock, valued at $1,212,497. This represents a 25.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Todd P. Kelsey sold 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $143.70, for a total value of $215,550.00. Following the completion of the transaction, the chief executive officer directly owned 69,214 shares of the company’s stock, valued at $9,946,051.80. This represents a 2.12% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,856 shares of company stock valued at $2,142,440. Company insiders own 1.76% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the company. Huntington National Bank increased its stake in shares of Plexus by 41.5% in the second quarter. Huntington National Bank now owns 324 shares of the technology company’s stock valued at $44,000 after buying an additional 95 shares during the period. TD Private Client Wealth LLC increased its stake in shares of Plexus by 185.6% in the first quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company’s stock valued at $66,000 after buying an additional 334 shares during the period. Banque Transatlantique SA acquired a new position in shares of Plexus in the first quarter valued at approximately $71,000. CWM LLC increased its stake in shares of Plexus by 65.7% in the second quarter. CWM LLC now owns 537 shares of the technology company’s stock valued at $73,000 after buying an additional 213 shares during the period. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Plexus by 583.3% in the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after buying an additional 490 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Articles
- Five stocks we like better than Plexus
- How to Profit From Value Investing
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- How to Profit From Growth Investing
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Catch the Next Bitcoin Rally With These 3 ETFs
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.